The following health care companies have a compelling forward dividend yield, one that is beating the dividend yield of the S&P 500 Index by nearly 200 basis points. The dividend yield of the benchmark for the U.S. equities market was 2.04% on Tuesday.
The closing share price of Diversicare Healthcare Services Inc. (DVCR, Financial) was $3.25 on Tuesday. Following a 64% decline for the 52 weeks through Jan. 22, the forward dividend yield went up to 6.67%, outperforming the industry by 235.2%. The stock has a market capitalization of $21.2 million and a price-sales ratio of 0.04 versus an industry median of 1.7.
The share price is slightly below the 50-day simple moving average line and far below the 100- and 200-day lines. The 52-week range is $2.14 to $9.61.
Diversicare provides skilled nursing health care services.
GuruFocus gave the company a financial strength rating of 4 out of 10 and a profitability and growth rating of 6 out of 10.
Patterson Companies Inc. (PDCO, Financial) closed at $22.03 per share on Tuesday. For the 52 weeks through Jan. 22, the share price declined 41%. The forward dividend yield is 4.67%. The stock has a market capitalization of about $2.09 billion, a price-book ratio of 1.43 versus an industry median of 2.12 and a price-earnings ratio of 13.21 versus an industry median of 19 and a price-sales ratio of 0.37 compared to an industry median of 0.91.
The share price is below the 200-, 100- and 50-day simple moving average lines. The closing price on Jan. 22 falls with the 52-week range of $18.94 to $38.20.
Patterson Companies sells dental and animal health products in North America and the United Kingdom.
GuruFocus rated Patterson Companies’ financial strength 6 out of 10 and its profitability and growth 7 out of 10.
During the third quarter, Joel Greenblatt started a position, purchasing 287,807 shares. Barrow, Hanley, Mewhinney & Strauss increased its holding by 91.96% to 5,968 shares.Ă‚ Ken Fisher (Trades, Portfolio) reduced his position by 0.29% to 106,596 shares, Mario Gabelli (Trades, Portfolio) decreased his holding by 2.18% to 2,080,860 shares and Charles Brandes (Trades, Portfolio) reduced his holding by 6.41% to 11,679 shares.
The recommendation rating is 3 out of 5, and the average target price is $22.22 per share.
Psychemedics Corp.'s (PMD, Financial) share price was $17.6 at close on Tuesday. The forward dividend yield is 3.97% versus an industry median of 1.10%. For the 52 weeks through Jan. 22, the stock has tumbled 16%. The market capitalization is approximately $97.09 million, the price-book ratio is 5.26 versus an industry median of 4.02, the price-earnings ratio is 16.19 versus an industry median of 35 and the price-sales ratio is 2.31 compared to an industry median of 3.81.
The share price is below the 200-day simple moving average line, but above the 50- and 100-day lines. The closing price on Tuesday was 26.3% above the 52-week low of $13.94 and 26.8% below the 52-week high of $22.31.
Psychemedics provides drug testing services in the U.S. and internationally.
GuruFocus has assigned the company a financial strength rating of 7 out of 10 and a profitability and growth rating of 8 out of 10.
Disclosure: I have no positions in any securities mentioned in this article.
Read more here:
